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Abstract 
 
Abstract: Here, we have taken a bottom-up approach to confer multidimensional structure to 
conductive polymers by attaching thiophene monomers to peptides predicted to self-assemble 
into a biomimetic, fibrous nanostructure. A library of 12 peptides containing covalently attached 
thiophene-based monomers was synthesized. Peptide sequences that resulted in self-assembly 
and hydrogel formation in aqueous media were identified and the physical and electrical 
properties were characterized. The resulting hybrid materials have conductivities in the range of 
10-2-10-3 S/cm, and possess moduli in the range of several tissue types, making them potential 
candidates for use in biomedical electronic applications.  
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Introduction 
Biocompatible conducting polymers (CPs) and hybrid materials with integrated CPs are of 
great interest to the medical field due to their electrical properties and tissue compatibility. Metal 
electrodes coated with CPs have been shown to reduce the formation of scar tissue at the 
electrode/tissue interface, which allows coated electrodes to function longer and with less 
damage to the body than traditional electrodes.1 However, the intrinsic brittleness associated with 
CPs due to their inflexible molecular structure gives rise to significant obstacles in the 
practicality of use beyond metal electrode coatings since CPs cannot be processed into useful 3D 
structures.2 In response to this problem, the development of an easily processable biocompatible 
CP material would extend the practical use of CPs into bio-stimulation, neural recording, drug 
delivery and artificial tissues. By engineering a hybrid peptide-CP material with tunable 
properties and physical morphology, the use of CPs for fields such as neuroscience and 
prosthetics can be achieved.   
Previous studies have shown that peptides with as few as four amino acid residues can 
assemble into fibrous gels in organic solvents that mimic the structure of soft tissues, giving rise 
to a hybrid material that could potentially be viable for in vivo applications.3 Other strategies 
have employed hydrogen-bonding interactions or pi-pi stacking of aromatic side chains to drive 
self-assembly into beta-sheets or beta-turns, which further associate into fibers.4-6 The 
combination of self-assembly motifs with CPs has led to the formation of hybrid materials 
featuring the desired electrical properties of the selected CP in a 3D network dictated by peptide 
self-assembly.7-9 Specifically, peptide-hybrids such as peptide-oligothiophene and peptide-3,4-
ethylenedioxythiophene (EDOT) derivatives have been analyzed and shown to form canonical 
structures based upon the amino acid sequence of the peptide, though no electrical 
characterization has been previously reported.8,9 The Murphy group has extensively explored 
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hexyl-GAGA-EDOT and found that while it supports the beta-sheet self-assembly motif, it is a 
poor candidate for in vivo applications.10 Hexyl-GAGA-EDOT does not assemble in aqueous 
solution and has unsuitable mechanical properties for biomedical applications.  
It would be advantageous to avoid organic solvents altogether, leading to the search for other 
peptide sequences that assemble in water and have robust physical and mechanical properties.11-
13 Beta-sheet forming peptides often have the sequence (ZXZX)n, where Z and X represent amino 
acid residues of alternating hydrophobicity.14 This alternation results in a peptide amphiphile 
with distinct faces; the hydrophobic faces tend to interact and sequester the hydrophobic side 
chains, presenting the hydrophilic residues on the opposite surface for interaction with solvent.14 
The exposed hydrophilic face offers opportunity to initiate assembly with pH changes, increasing 
the likelihood of creating a peptide hydrogel. Sequences containing repeats of glycine (G) and 
alanine (A) form hydrogels with pH-dependent nanostructures, while those containing repeat 
units of valine (V) and threonine (T) have a strong tendency to form beta-sheets and aggregate 
into microscale fibrous structures.11 Sequences containing glutamic acid (E) and V also exhibit 
strong beta-sheet character in aqueous media, making them promising candidates for gelation.11  
In our study, peptide sequences containing V and E were selected for their propensity to form 
beta-sheets in aqueous media.11 Similarly, A was selected as the C-terminus amino acid in each 
peptide for its known presence in beta-sheet forming sequences and its apparent sensitivity to pH 
changes during gelation.11 Isoleucine (I) and aspartic acid (D) offered variability in the length of 
the hydrophobic and acidic side chains by one carbon each. Leucine (L) offered additional 
variability in the length of the hydrophobic side chain, and phenylalanine (F) offered a rigid, 
hydrophobic structure capable of pi-stacking interactions. A library of 12 peptides was 
constructed from these amino acids based on three variables: identity of the hydrophobic residue, 
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identity of the acidic residue, and grouping of the hydrophobic residues (Figure 1). The identity 
of hydrophobic and acidic residues was systematically varied to test assembly strength based on 
side chain length, while hydrophobic residues were alternated to increase the size of the library 
and modulate the strength of assembly. 
 
Figure 1. Chemical structures of the peptide library.  
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Here, we present the synthesis, characterization and evaluation of the 12-peptide library shown 
above. Eight of the 12 peptides were capable of gelation, and mechanical analysis indicates that 
this subset of peptides may also be injectable, increasing relevance for biomedical applications. 
Additionally, mechanical testing revealed gel densities compatible with human soft tissues, most 
notably brain and heart. All gels exhibiting self-assembly retained beta-sheet content and fibrous 
networks after polymerization and exhibited conductivity values on par with literature.  
 
Materials and Methods 
Chemicals and Instrumentation: All solvents and reagents were purchased from SigmaAldrich, 
EMDMillipore, AnaSpec, Strem Chemicals, Fisher Chemical, Novabiochem or Chem-Impex 
International and used without further purification. NMR data was collected on a Bruker 500 
MHz spectrometer. FTIR spectra were collected using a Thermo Scientific Nicolet iS10 FRIT 
equipped with an attenuated total reflectance (ATR) accessory. HPLC-MS was performed on an 
Advion Expression LCMS with a Thermo Scientific Dionex UltiMate 3000 HPLC equipped with 
diode array UV-Vis spectrophotometer. Rheology experiments were performed with a TA 
Instruments Discovery Hybrid Rheometer-2 and TRIOS software. SEM imaging was performed 
on a Vega TS 5136MM SEM or JEOL JSM-7200F SEM. Resistivity measurements were made 
using a Lucas Labs Pro-4 four-point probe equipped with a Signatone SP4-40045TBY tip and 
powered by a Keithley 2400 SourceMeter. 
Wang Solid Phase Peptide Synthesis (SPPS): The grams and moles of each reagent used are 
given in Table 1. Plastic fritted syringes (24 mL) were loaded with Wang-Ala-9-
fluorenylmethoxycarbonyl (Fmoc) resin (0.71 mmol/g linker). The resin was rinsed twice with 
dichloromethane (DCM, 9 mL/rinse), and then rinsed 3x in N,N-dimethylformamide (DMF, 9 
mL/rinse). To remove the Fmoc protecting group before each coupling, the resin-peptide was 
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soaked in 20% (v/v) piperidine/DMF (9 mL/rinse) for 5 min, rinsed with the same solution, then 
rinsed 3x with DMF. For each coupling, N,N,N’,N’-tetramethyl-O-(1H-benzotriazol-1-
yl)uronium hexafluorophosphate (HBTU) was combined with the appropriate amino acid or with 
3-thiopheneacetic acid dissolved in 25% (v/v) diisopropylethylamine (DIPEA)/DMF (4.2 
mL/coupling) for 5 min, then transferred to the fritted syringe to couple for 30 min. The finished 
peptide-thiophene derivatives were rinsed 3x with methanol, 3x with DMF, and 3x with DCM (9 
mL/rinse). The peptides were then cleaved from the resin by soaking in 95% trifluoroacetic acid 
(TFA) containing 2.5% H2O and 2.5% triisopropylsilane (TIPS) (9 mL) for 1 h. The peptide-
TFA solution was eluted from the syringe, and the resin was rinsed twice more with the cleavage 
solution (9 mL/rinse). The TFA solution was removed by rotary evaporation, and each peptide 
was precipitated into -78 °C diethyl ether (100 mL), transferred to four 50 mL Falcon centrifuge 
tubes, and centrifuged for 10 min (4000 rpm at -4 °C). The supernatant was drained and 
discarded, and the pellets were resuspended twice in 20 mL cold ether, centrifuged, and drained. 
The pellets dried overnight or were dried under high vacuum (4 h), then were resuspended in 
nanopure H2O (6 mL/tube) and lyophilized. 
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Table 1. Wang SPPS reactants 
 
 
 
 
 
 
 
 
 
 
Thiophene-VEVA was isolated as a fluffy white solid (0.130 g, 68% yield); ATR-FTIR 
(lyophilized, neat): νmax/cm-1 3278 (N-H), 2967 (sp3 C-H), 1636 (amide I C=O), 1547 (amide II 
N-H bend), 1455 (C-H bend). 1H-NMR (DMSO-d6, 500 MHz): δ (ppm) 0.80-0.92 (m, 9H), 1.26 
(d, J = 7.5 Hz,  3H), 1.69-1.77 (m, 1H), 1.84-1.99 (m, 3H), 2.17-2.30 (m, 2H), 3.46-3.57 (m, 
2H), 4.15-4.20 (m, 3H), 4.29-4.33 (m, 1H), 7.01-7.03 (m, 1H), 7.23-7.24 (m, 1H), 7.43-7.44 (m, 
1H), 7.68 (d, J  = 10 Hz, 1H), 8.05 (d, J = 10 Hz, 1H), 8.11 (d, J = 10 Hz, 1H) 8.22 (d, J = 10 Hz, 
1H). ESI-MS m/z: 541.2 [M + H]+ (calc. 541.2) 
Thiophene-VVEA was isolated as a fluffy white solid (0.101 g, 52% yield); ATR-FTIR 
(lyophilized, neat): νmax/cm-1 3273 (N-H), 2967 (sp3 C-H), 1635 (amide I C=O), 1541 (amide II 
N-H bend), 1456 (C-H bend). 1H-NMR (DMSO-d6, 500 MHz): δ (ppm) 0.80-0.87 (m, 12H), 
1.26 (d, J = 5 Hz, 3H), 1.68-1.76 (m, 1H), 1.85-1.99 (m, 3H), 2.16-2.27 (m, 2H), 3.46-3.55 (m, 
2H), 4.14-4.20 (m, 3H), 4.28-4.33 (m, 1H), 7.02 (d, J = 5 Hz, 1H), 7.23 (d, J = 5 Hz, 1H), 7.42-
Reactant Mass (g) mmol 
Wang-Ala-Fmoc Resin 0.500 0.355 
HBTU 0.539 1.42 
Fmoc-Val-OH 0.482 1.42 
Fmoc-Ile-OH 0.502 1.42 
Fmoc-Phe-OH 0.550 1.42 
Fmoc-Leu-OH 0.502 1.42 
Fmoc-Asp(OtBu)-OH 0.584 1.42 
Fmoc-Glu(OtBu)-OH 0.604 1.42 
3-thiopheneacetic acid 0.202 1.42 
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7.44 (m, 1H), 7.85-7.91 (m, 1H), 8.05 (d, J = 10 Hz, 1H), 8.13 (d, J = 10 Hz, 1H). ESI-MS m/z: 
541.2 [M + H]+ (calc. 541.2) 
Thiophene-VDVA was isolated as a white powder; ATR-FTIR (lyophilized, neat): νmax/cm-1 
3271 (N-H), 3079 (sp2 C-H), 2962 (sp3 C-H), 1704 (carboxylic acid C=O), 1633 (amide I C=O), 
1539 (amide II N-H bend). 1H-NMR (DMSO-d6, 500 MHz): δ (ppm) 0.79-0.99 (m, 12H), 1.26 
(d, J = 10 Hz, 3H), 1.93-1.97 (m, 1H), 2.67-2.72 (m, 1H), 3.545-3.59 (m, 2H), 4.15-4.22 (m, 
3H), 4.55-4.60 (m, 1H), 7.02 (dd, J = 5, 5 Hz, 1H), 7.24 (d, J = 5 Hz, 1H), 7.43-7.48 (m, 2H), 
8.05 (d, J = 5 Hz, 1H), 8.21 (d, J = 10 Hz, 1H), 8.37 (d, J = 10 Hz, 1H), 12.38 (s, 2H). ESI-MS 
m/z: 527.2 [M + H]+ (calc. 527.2) 
Thiophene-VVDA was isolated as a white powder; ATR-FTIR (lyophilized, neat): νmax/cm-1 
3271 (N-H), 3079 (sp2 C-H), 2962 (sp3 C-H), 1704 (carboxylic acid C=O), 1634 (amide I C=O), 
1539 (amide II N-H bend), 1453 (C-H bend). 1H-NMR (DMSO-d6, 500 MHz): δ (ppm) 0.79-
0.99 (m, 11H), 1.24 (d, J = 5 Hz, 3H), 1.92-1.98 (m, 2H), 2.65-2.69 (m, 1H), 3.46-3.56 (m, 2H), 
4.13-4.22 (m, 3H), 4.54 (sextet, J = 3 Hz, 1H), 7.01 (m, 1H), 7.22-7.23 (m, 1H), 7.42-7.44 (m, 
1H), 7.80 (d, J = 5 Hz, 1H), 7.91 (d, J = 5 Hz, 1H), 8.05 (d, J = 5 Hz, 1H), 8.17 (d, J = 5 Hz, 
1H), 12.44 (s, 2H). ESI-MS m/z: 527.3 [M + H]+ (calc. 527.2) 
Thiophene-IEIA was isolated as a white powder (0.112 g, 53% yield); ATR-FTIR (lyophilized, 
neat): νmax/cm-1 3279 (N-H), 3080 (sp2 C-H), 2965 (sp3 C-H), 1732 (carboxylic acid C=O), 1633 
(amide I C=O), 1547 (amide II N-H bend), 1455 (C-H bend). 1H-NMR (DMSO-d6, 500 MHz): δ 
(ppm) 0.76-0.86 (m, 12H), 1.08-1.11 (m, 2H), 1.26 (d, J = 10 Hz, 3H), 1.36-1.46 (m, 2H), 1.67-
1.75 (m, 3H), 1.83-1.96 (m, 1H), 2.09-2.21 (m, 4H), 3.45-3.45 (m, 2H), 4.14-4.22 (m, 3H), 4.30 
(sextet, J = 5 Hz, 1H), 7.01 (q, J = 5 Hz, 1H), 7.22-7.23 (m, 1H), 7.42-7.43 (m, 1H), 7.66 (d, J = 
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10 Hz, 1H), 8.07-8.12 (m, 2H), 8.24 (d, J = 10 Hz, 1H). ESI-MS m/z: 569.2 [M + H]+ (calc. 
569.3)  
Thiophene-IIEA was isolated as a white powder; ATR-FTIR (lyophilized, neat): νmax/cm-1 
3270 (N-H), 3078 (sp2 C-H), 2962 (sp3 C-H), 1704 (carboxylic acid C=O), 1633 (amide I C=O), 
1543 (amide II N-H bend), 1454 (C-H bend). 1H-NMR (DMSO-d6, 500 MHz): δ (ppm) 0.76-
0.99 (m, 11H), 1.08-1.11 (m, 2H), 1.26 (d, J = 10 Hz, 3H), 1.38-1.42 (m, 2H), 1.69-1.74 (m, 2H), 
1.85-1.90 (m, 1H), 2.22-2.26 (m, 2H), 3.45-3.52 (m, 2H), 4.14-4.29 (m, 4H), 6.99 (q, J = 5 Hz, 
1H), 7.21 (s, 1H), 7.42-7.44 (m, 1H), 7.89-7.92 (m, 1H), 8.08 (d, J = 5 Hz, 1H), 8.14 (d, J = 5 
Hz, 1H), 12.31 (s, 2H). ESI-MS m/z: 569.3 [M + H]+ (calc. 569.3) 
Thiophene-IDIA was isolated as a white powder; ATR-FTIR (lyophilized, neat): νmax/cm-1 
3270 (N-H), 3078 (sp2 C-H), 292 (sp3 C-H), 1705 (carboxylic acid C=O), 1633 (amide I C=O), 
1539 (amide II N-H bend), 1454 (C-H bend). 1H-NMR (DMSO-d6, 500 MHz): δ (ppm) 0.76-
0.84 (m, 12H), 0.94-1.09 (m, 3H), 1.27 (d, J = 10 Hz, 3H), 1.36-1.44 (m, 2H), 1.67-1.73 (m, 2H), 
2.66-2.71 (m, 1H), 3.44-3.57 (m, 2H), 4.15-4.32 (m, 3H), 4.57-4.60 (m, 1H), 7.01 (d, J = 5 Hz, 
1H), 7.23 (d, J = 5 Hz, 1H), 7.42-7.44 (m, 1H), 7.49 (d, J = 10 Hz, 1H), 8.07 (d, J = 10 Hz, 1H), 
8.20 (d, J = 5 Hz, 1H),  8.37 (d, J = 5 Hz, 1H), 12.38 (s, 2H). ESI-MS m/z: 555.3 [M + H]+ (calc. 
555.2) 
Thiophene-IIDA was isolated as a white powder in a previous synthesis; ATR-FTIR 
(lyophilized, neat): νmax/cm-1 3270 (N-H), 3078 (sp2 C-H), 2962 (sp3 C-H), 1704 (carboxylic acid 
C=O), 1633 (amide I C=O), 1539 (amide II N-H bend), 1454 (C-H bend). 1H-NMR (DMSO-d6, 
500 MHz): δ (ppm) 0.76-0.80 (m, 12H), 1.03-1.07 (m, 3H), 1.25 (d, J = 10 Hz, 3H), 1.38-1.41 
(m, 2H), 1.68-1.72 (m, 2H), 2.65-2.69 (m, 1H), 3.45-3.53 (m, 2H), 4.14-4.21 (m, 3H), 4.52-4.56 
9 
 
(m, 1H), 7.00 (d, J = 5 Hz, 1H), 7.22 (s, 1H), 7.42-7.44 (m, 1H), 7.82-7.89 (m, 2H), 8.08 (d, J = 
10 Hz, 1H), 8.17 (d, J = 10 Hz, 1H). ESI-MS m/z: 555.3 [M + H]+ (calc. 555.2) 
Thiophene-LELA was isolated as a fluffy white solid (0.099 g, 49% yield); ATR-FTIR 
(lyophilized, neat): νmax/cm-1 3274 (N-H), 3080 (sp2 C-H), 2957 (sp3 C-H), 1715 (carboxylic acid 
C=O), 1634 (amide I C=O), 1544 (amide II N-H bend), 1455 (C-H bend). 1H-NMR (DMSO-d6, 
500 MHz): δ (ppm) 0.78-0.88 (m, 12H), 1.26 (d, J = 5 Hz, 3H), 1.41-1.45 (m, 4H), 1.54-1.64 (m, 
1H), 1.70-1.74 (m, 1H), 1.85-1.91 (m, 2 H), 3.42-3.51 (m, 2H), 4.15-4.33 (m, 4H), 7.00 (d, J = 5 
Hz, 1H), 7.22 (s, 1H), 7.42-7.43 (m, 1H), 7.79 (d, J = 5 Hz, 1H), 8.06 (d, J = 5 Hz, 1H), 8.15-
8.19 (m, 2H). 
Thiophene-LLEA was isolated as a fluffy white solid (0.098 g, 48% yield); ATR-FTIR 
(lyophilized, neat): νmax/cm-1 3262 (N-H), 3079 (sp2 C-H), 2958 (sp3 C-H), 1714 (carboxylic acid 
C=O), 1630 (amide I C=O), 1540 (amide II N-H bend), 1452 (C-H bend). 1H-NMR (DMSO-d6, 
500 MHz): δ (ppm) 0.80-0.87 (m, 12H), 1.26 (d, J = 5 Hz, 3H), 1.42-1.46 (m, 4H), 1.53-1.59 (m, 
2H), 1.74-1.75 (m, 1H), 1.87-1.91 (m, 1H), 2.23-2.26 (m, 2H), 3.42-3.49 (m, 2H), 4.15-4.18 (m, 
1H), 4.24-4.32 (m, 3H), 6.99-7.00 (m, 1H), 7.21-7.22 (m, 1H), 7.42-7.44 (m, 1H), 7.79 (d, J = 10 
Hz, 1H), 8.01 (d, J = 10 Hz, 1H), 8.14-8.19 (m, 2H). 
Thiophene-FEFA was isolated as a fluffy white solid (0.154 g, 68% yield); ATR-FTIR 
(lyophilized, neat): νmax/cm-1 3281 (N-H), 3064 (sp2 C-H), 1711 (carboxylic acid C=O), 1633 
(amide I C=O), 1520 (amide II N-H bend), 1454 (C-H bend). 1H-NMR (DMSO-d6, 500 MHz): δ 
(ppm) 1.29 (d, J = 10 Hz, 3H), 1.65-1.73 (m, 1H), 1.80-1.87 (m, 1H), 2.12-2.20 (m, 2H), 2.68-
2.81 (m, 2H), 2.95 (dd, J = 12.5, 5 Hz, 1H), 3.06 (dd, J = 12.5, 5 Hz, 1H), 3.38 (q,  J = 10 Hz, 
2H), 4.21 (quint, J = 5 Hz, 2H), 4.50-4.57 (m, 2H), 6.80 (dd, J = 5, 5 Hz, 1H), 7.02 (s, 1H), 7.14-
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7.36 (m, 10H), 7.93 (d, J = 10 Hz, 1H), 8.10 (d, J = 5 Hz, 1H), 8.21 (d, J = 10 Hz, 1H), 8.32 (d, J 
= 10 Hz, 1H). 
Thiophene-FFEA was isolated as a fluffy white solid (0.110 g, 49% yield); ATR-FTIR 
(lyophilized, neat): νmax/cm-1 3285 (N-H), 2931 (sp3 C-H), 1710 (carboxylic acid C=O), 1632 
(amide I C=O), 1520 (amide II N-H bend), 1452 (C-H bend). 1H-NMR (DMSO-d6, 500 MHz): δ 
(ppm) 1.26 (d, J = 5 Hz, 3H), 1.74-1.81 (m, 1H), 1.88-1.95 (m, 1H), 2.28 (t, J = 10 Hz, 2H), 
2.68-2.72 (m, 1H), 2.79-2.84 (m, 1H), 2.95-3.04 (m, 2H), 3.38 (q, J = 10 Hz, 2H), 4.19 (sextet, J 
= 5 Hz, 1H), 4.30-4.42 (m, 1H), 4.48-4.58 (m, 2H), 6.77-6.79 (m, 1H), 6.99 (s, 1H), 7.14-7.29 
(m, 10H), 7.35-7.36 (m, 1H), 8.07 (d, J = 5 Hz, 1H), 8.13 (d, J = 5 Hz, 1H), 8.18 (d, J = 5 Hz, 
1H), 8.23 (d, J = 10 Hz, 1H). 
Gelation Procedure: Table 2 lists the specific amounts of the reagents used for this procedure. 
Lyophilized peptide-thiophene derivatives and (2,3-dihydrothieno[3,4-b][1,4]dioxin-2-
yl)methanol (EDOT-OH, 1:1 mol ratio) were weighed into 4.5 mL polypropylene shell vials. 
Nanopure H2O and NaOH (1 M) were added until the peptide was fully solubilized upon 
sonication. p-TSA (0.2 M) was added to the solution while sonicating to induce gelation (Table 
4). Gels formed immediately following acidification except in the case of VVEA, which was left 
to rest for 1 d at rt before gelation was assessed. Gels were stored tightly capped at rt and 
allowed to rest a minimum of 4 h before characterization. 
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Table 2. Standard components for 1% (w/v) gels 
Peptide Peptide Mass 
(mg) 
EDOT-OH Mass 
(mg) 
np H2O 
(µL) 
1 M NaOH 
(µL) 
0.2 M p-TSA 
(µL) 
VEVA 5.0 1.6 339 23.0 138 
VVEA 5.0 1.6 339 23.0 138 
IEIA 5.0 1.5 345 22.0 133 
IIEA 5.0 1.5 345 22.0 133 
VDVA 5.0 1.6 345 22.0 133 
VVDA 5.0 1.6 345 22.0 133 
IDIA 5.0 1.5 351 21.0 128 
IIDA 5.0 1.5 351 21.0 128 
 
Polymerization Procedure: Homogenous gels were injected at rt with a 40 µL FeCl3 solution 
(1:1 mol ratio FeCl3:CP) using a 27 gauge needle. The needle was used to pierce the body of the 
gel, and the solution was slowly and evenly injected as the needle was withdrawn from the gel. 
The gels were then capped and placed in a 50 °C incubator until polymerization was complete 
(48 h). Polymerized gels were rinsed gently 3x with 1 mL npH2O, then soaked 3x in 1.5 mL 
npH2O (20 min); washes were discarded and polymerized gels were stored at room temperature. 
Rheological Testing Parameters: Mechanical testing was performed on 1% (w/v) gels at 37 
°C. Enough gel was added to fill the 25-mm parallel plates at a gap distance of 530 μm, after 
which a fixed strain of 0.05 or 0.1% was applied from 0.1-10 Hz for 5 data points/decade as the 
result of 3 iterative trials/point with 5% tolerance. Storage and loss moduli were recorded 
alongside complex viscosity and averaged by gel identity. Data was collected in triplicate and 
averaged unless otherwise noted. 
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Conductivity Testing: Conductivity testing was performed on polymerized gels after washing 
gently with water to remove residual monomer and excess FeCl3. Gels were lyophilized and 
pellet-pressed, then analyzed via 4-point probe. Ten resistance data points were collected and 
averaged, then converted to resistivity using the thickness of the pellet (Appendix C, Equations 1 
and 2). 
SEM Images: Gelled peptide derivatives were lyophilized and individually applied to carbon 
tape on SEM stubs. Polymerized gel samples were washed gently, lyophilized and individually 
applied to carbon tape on SEM stubs. The stubs were dried by vacuum desiccator overnight. 
Samples were sputter coated for 60 or 90 s with a Pd/Au mixture. Images were captured at 
magnifications ranging between 1 kx and 75 kx for each peptide. Imaging on the Vega TS 
5136MM SEM was performed at an accelerating voltage of 15 kV. Imaging performed on the 
JEOL JSM-7200F SEM utilized either SEM mode with an accelerating voltage between 3 and 20 
kV, or in gentle beam mode with an accelerating voltage of 1 kV.  
 
 
Results and Discussion 
Peptide Synthesis, Purification, and Characterization 
The 12 tetrapeptide derivatives shown in Figure 1 were synthesized on Wang resin using 
standard Fmoc-based methods. Each peptide was N-acylated using 3-thiopheneacetic acid while 
on-resin. The peptides were precipitated and washed with ether, dried, lyophilized and used with 
no further purification. Peptide structure and purity were analyzed by NMR and HPLC-MS 
(Appendix A).  
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Gelation 
As outlined in Figure 2, gels were created by combining the lyophilized peptide and EDOT-
OH in water to make a 1% (w/v) peptide solution. A small aliquot of sodium hydroxide (NaOH, 
1M) was added to solubilize the peptides. This mixture was sonicated until the peptide and 
EDOT-OH had fully dissolved, after which an aqueous solution of para-toluenesulfonic acid (p-
TSA, 0.2 M) was added to induce gelation. p-TSA was used as the acid to protonate the peptide 
and serve as a dopant for the subsequent polymerization reactions. The resulting homogenous 
gels were subjected to characterization after resting a minimum of 4 h at room temperature. 
While the majority of the peptides containing V and I hydrophobic residues consistently formed 
homogeneous gels, VEVA and IEIA occasionally formed heterogeneous, segmented gels (Table 
3). Successful gels had optical properties ranging from opaque to transparent. In general, gels 
containing a D moiety were more transparent than those containing an E moiety. The four D 
derivatives were either transparent in the case of VDVA and VVDA, or nearly transparent in the 
case of IDIA and IIDA. VEVA gels were opaque, and the IEIA and IIEA gels were nearly 
opaque (Table 3). Gelation of L and F peptides was attempted unsuccessfully. L-based peptides 
immediately precipitated out of solution with the addition of acid, while F-based gels formed 
transiently but collapsed over the course of several hours (Table 3, Appendix B). Due to their 
inability to stably self-assemble, exploration of the four peptides containing L or F was 
discontinued.  
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Figure 2. Representative gelation process illustrated with VEVA.  
 
Table 3. Average quality of 1% (w/v) gels pre- and post-polymerization. 
Peptide Homogeneity Clarity Stability Polymerized Stability 
VEVA Often 5 Strong Variable 
VVEA Always 3 Moderate Moderate 
VDVA Always 1 Strong Strong 
VVDA Always 1 Strong Strong 
IEIA Often 4 Strong Strong 
IIEA Always 4 Weak Variable 
IDIA Always 2 Strong Strong 
IIDA Always 2 Weak Strong 
LELA Precipitate 5 N/A N/A 
LLEA Precipitate 5 N/A N/A 
FEFA Transient 5 Weak N/A 
FFEA Transient 5 Weak N/A 
1 = Transparent  3 = Translucent  5 = Opaque 
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Fourier transform infrared spectroscopy (FTIR) was performed on lyophilized gels to detect 
the presence of secondary structure. p-TSA peaks present from acidification were observed 
below 1450 cm-1 and contributed to sp2 and sp3 C-H stretching peaks. All gels exhibited N-H 
stretching modes near 3275 cm-1, sp2 C-H stretching near 3060 cm-1, sp3 C-H stretching between 
2850 cm-1 and 3000 cm-1, a carboxylic acid C=O stretch near 1715 cm-1, an amide I (C=O) peak 
near 1630 cm-1, and an amide II (N-H bend) peak near 1540 cm-1 (Figure 3). The amide I peak is 
diagnostic of secondary structure in proteins and peptides; an amide I peak between 1620 cm-1 
and 1629 cm-1 with a weak shoulder near 1695 cm-1 indicates antiparallel beta-sheets, while an 
amide I peak between 1620 cm-1 and 1629 cm-1 with a weak shoulder near 1640 cm-1 indicates 
parallel beta-sheets (Figure 4).15 An amide I peak observed above 1650 cm-1 indicates the 
presence of alpha-helices or disorder. The amide I peak of the 8 peptides that formed gels fell 
between 1629 cm-1 and 1633 cm-1, suggesting the presence of beta-sheets. However, no obvious 
shoulders were observed that would distinguish parallel from anti-parallel beta-sheets. Circular 
dichroism (CD) spectroscopy could be used to address the orientation of beta-sheets, however, 
the thiophene moiety covalently attached to the N-termini of the peptides has a UV absorbance 
that interferes with secondary structure determination by CD.  
 
16 
 
 
Figure 3. FTIR spectra of gelled peptides indicating assembly into beta-sheets. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Arrangement of molecules in parallel (top) and antiparallel (bottom) beta-sheets. 
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SEM images were collected of lyophilized gels prior to polymerization to characterize physical 
properties and assess the presence of a fibrous, biomimetic structure. Several peptide gels remain 
to be characterized by SEM. Of those gels characterized, low magnification imaging reveals both 
sheet-like and globular morphologies. These features vary in size between gels, but variation 
appears determined by sample preparation and handling and does not seem to signify an intrinsic 
property of the gel. A representative low magnification image of unpolymerized VDVA (Figure 
5A) reveals sheets and indicates some porosity. Higher magnification imaging of the same 
sample (Figure 5B) reveals the presence of fibers, suggesting that fibers compose the larger 
structures observed in low magnification imaging. These fibers form through the association of 
beta-sheets.  
 
 
Figure 5. Representative SEM images of unpolymerized VDVA at A) low magnification 
revealing microscale morphology, and at B) high magnification revealing a nanoscale fibrous 
morphology. 
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Gel Polymerization and Electrical Characterization  
To polymerize the gels and render them conductive, homogenous gels were injected with a 
solution of iron (III) chloride (FeCl3), then incubated at 50 °C for 48 h (Figure 6). The 
polymerized gels were rinsed gently with water prior to characterization. Polymerization 
disrupted VEVA and IIEA gels in some cases, resulting in a collapse of the 3D structure or a loss 
of robustness accompanied by a change in texture from smooth to gritty (Table 3). This structural 
failure was observed most frequently in IIEA, which was the gel with the lowest storage modulus 
before polymerization and the second lowest after polymerization (Table 5). VEVA also 
exhibited periodic disruption during polymerization, contrary to the mid-level storage modulus 
observed both before and after polymerization associated with VEVA gels.  
 
 
Figure 6. Representatives photographs of the gel polymerizations. VVDA gel A) before, B) 
during, and C) after polymerization.  
FTIR spectroscopy was performed on lyophilized polymerized gels to analyze retention of 
secondary structure after polymerization. Spectra of VDVA before and after polymerization are 
shown in Figure 7, and are representative of all the gels (See Appendix C, F1 for the complete 
A B C 
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set of spectra).  p-TSA peaks were observed below 1450 cm-1 and contributed to the sp2 and sp3 
C-H stretching peaks. All gels exhibited N-H stretching modes near 3275 cm-1, weak sp2 C-H 
stretching near 3060 cm-1, sp3 C-H stretching between 2850 cm-1 and 3000 cm-1, a carbonyl C=O 
stretch near 1715 cm-1, an amide I peak near 1630 cm-1, and an amide II peak near 1540 cm-1 
(CF1, Figure 7). These positions of these peaks match well with the observed peaks in 
unpolymerized gel samples, indicating that the polymerization process did not impact gel 
assembly. Specifically, the amide I peaks did not shift away from 1630 cm-1, confirming 
retention of beta-sheets after polymerization. Following polymerization, gels are insoluble and 
could not be analyzed through alternative spectroscopic methods.  
 
 
Figure 7. FTIR spectra of VDVA pre- and post-polymerization indicating retention of beta-sheet 
assembly. See also CF1.  
 
SEM imaging of gels was performed to analyze gel morphology post-polymerization. Figure 
8A shows unpolymerized VDVA (also shown in Figure 5B) next to polymerized VDVA (Figure 
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8B) at a similar magnification. Fibers are evident in PVDVA, supporting the conclusion that 
polymerization did not disrupt beta-sheet assembly. High magnification imaging of PVVDA 
(Figure 8D) shows an entangled fiber network with fiber diameters measured between 7 and 15 
nm. This fibrous network would allow nutrient exchange if a polymerized gel were implanted 
into human tissue, validating the design criteria selected to encourage peptide beta-sheet 
assembly. 
 
 
 
Figure 8. SEM micrographs of fibrous networks shown A) in VDVA before polymerization, B) 
in VDVA after polymerization, C) at low magnification in VVDA after polymerization, and D) 
at high magnification in PVVDA. PVVDA fibers ranged between 7 and 15 nm in diameter.  
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Conductivity Testing 
Conductivity testing was performed on polymerized gels after washing gently with water to 
remove residual monomer and excess FeCl3. Each gel was lyophilized then compressed into a 
pellet and analyzed by 4-point probe to determine sheet resistivity. Sheet resistivity was 
converted into resistivity, then to conductivity according to Equation 1 and 2 (Appendix C). All 
library members displayed conductivity of approximately 10-2 S/cm (Table 4), reaching the low 
end of the PEDOT range (10-2 – 102 S/cm) and approaching that of undoped silicon (10-1 S/cm). 
These values are comparable to or better than literature hydrogel conductivity values using 
thiophene-based CPs with polymer-based hydrogels and comparable to values obtained using 
polydopamine-carbon-nanotube hydrogels.16-18 Each of the eight library members have 
conductivity at least one order of magnitude greater than recently published papers concerning 
peptide-CP hydrogels.10 There does not appear to be a correlation between conductivity and 
assembly strength (Tables 4, 5). 
 
Table 4. Electrical properties of gels 
  VEVA  VVEA* IEIA* IIEA* VDVA  VVDA  IDIA  IIDA* 
ρ (Ω‧cm) 367  102 450 119 118 110 66.5 105 
σ (S/cm)  3.1E-3 9.9E-3  2.2E-3 8.4E-3 8.5E-3 9.1E-3 1.5E-2 9.6E-3 
* One trial 
Unmarked: Two trials 
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Rheological Testing 
Mechanical testing was performed on 1% gels of each peptide before and after polymerization. 
Eight gels were produced from each peptide, half of which were subsequently polymerized 
following standard procedure. Rheology was then performed using parameters developed from 
literature standards and adapted to the moduli of the peptide hydrogels.18,19 Briefly, gels were 
oscillated at varying frequency with a fixed strain percent within the viscoelastic region of each 
gel. Reported values are the average of triplicate trials irrespective of the frequency at which the 
point was collected. 
Mechanical testing results (Table 5, Figure 9, Appendix C: CF2, CF3) did not offer a clear 
pattern for determining the storage modulus of a gel from its peptide sequence, though several 
intermediate conclusions have been reached. First, I-based gels with grouped hydrophobic 
residues (IIEA, IIDA) possessed the lowest overall storage moduli at 20.0 ± 5.7 kPa and 35.5 ± 
9.0 kPa respectively before polymerization, nearly an order of magnitude lower than the isomeric 
peptides with alternating hydrophobicity (IDIA, IEIA) which had resultant storage moduli of 
97.8 ± 14.5 kPa and 94.7 ± 7.8 kPa before polymerization. Polymerization resulted in storage 
moduli of 44.0 ± 14.2 kPa (PIEIA) and 80.6 ± 19.0 kPa (PIDIA) for the I-based gels with 
alternating hydrophobicity, while the I-based gels with grouped hydrophobic residues retained 
the lowest storage moduli after polymerization at measured values of 28.0 ± 8.7 kPa and 27.8 ± 
5.3 kPa (PIIDA). These results indicate that I-based gels assemble more robustly when the 
hydrophobic residues alternate with the hydrophilic residues.  
 A conclusive pattern was not observed in the behavior of I-based peptide assembly with 
consideration to the acidic residue present in the peptide. With measured storage moduli of 97.8 
± 14.5 kPa (IEIA) versus 94.7 ± 7.8 kPa (IDIA) and 20.0 ± 5.7 kPa (IIEA) versus 35.5 ± 9.0 kPa 
(IIDA) before polymerization, the storage moduli range of peptides with the same 
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hydrophobicity pattern and different acidic residue identity overlap or nearly overlap. 
Polymerized gels exhibited storage moduli of 44.0 ± 14.2 kPa (PIEIA) versus 80.6 ± 19.0 kPa 
(PIDIA) and 28.0 ± 8.7 kPa (PIIEA) versus 27.8 ± 5.3 kPa (PIIDA), indicating a potential 
preference for D in the I-based gels with alternating hydrophobic groups (PIEIA, PIDIA). 
However, the large error margins associated with PIEIA and PIDIA suggest that more testing is 
necessary before concluding the difference in I-based gel strength related to the acidic residues is 
significant. Additionally, the 50.7 kPa decrease in modulus observed after polymerization in 
IEIA gels (94.7 kPa to 44.0 kPa) may indicate that data for the PIEIA samples is not 
representative of the true assembly strength of those gels. A larger sample size is necessary 
before determining a pattern based on the identity of the acidic residue in I-based gels. 
Contrary trends were observed in the storage moduli of V-based gels compared to those of I-
based gels. Gels with grouped hydrophobic residues performed equally with those of alternating 
hydrophobicity and E residues in the case of VVEA and VEVA, with measured moduli of 92.7 ± 
20.4 kPa (VVEA) and 85.5 ± 8.1 kPa (VEVA) before polymerization. A preference for 
alternating hydrophobicity appears in the case of V gels with D residues, as VVDA has a lower 
storage modulus (74.1 ± 4.3 kPa) compared to that of VDVA (117 ± 16.0 kPa) before 
polymerization. After polymerization, PVEVA possessed a measured modulus 32.1 kPa higher 
than that of PVVEA (67.9 ± 2.1 kPa versus 35.8 ± 7.7 kPa); only two replicates were measured 
for PVEVA, but the narrow error margins suggest that the average value is accurate. A 56.9 kPa 
decrease was observed in the modulus of PVVEA after polymerization (35.8 ± 7.7 versus 92.7 ± 
20.4 before polymerization). V-based gels containing D residues exhibited a slight preference for 
grouped hydrophobic residues, as PVVDA exhibits a 16.9 kPa greater modulus than PVDVA 
(117 ± 3.9 versus 100.1 ± 6.7 respectively). The effects of hydrophobic residue placement and 
24 
 
acidic residue identity appear to interact in V gels, leaving no clear method to predict which V-
based sequence will possess the highest moduli when considering a library. 
Overall, V-based sequences were superior to I-based sequences in almost every case before 
polymerization, with the single exception observed in unpolymerized IEIA exhibiting a higher 
modulus (97.8 ± 14.5 kPa) than VEVA (85.5 ± 8.1 kPa). V gels consistently demonstrated higher 
storage moduli than I gels after polymerization, with the greatest disparity observed between 
PVVDA (117 ± 3.9 kPa) and PIIDA (27.8 ± 5.3 kPa). PVVDA exhibited the highest storage 
modulus at 117 kPa, followed by VDVA measured at 100 kPa. Apart from IIEA and VVDA, 
samples showed a decrease in storage modulus after polymerization. Gels were expected to have 
higher moduli after polymerization due to the extensive network of covalent bonds distributed 
throughout the gel by the polymer chains, but only two samples showed an increase in modulus 
post-polymerization. General trends observed in loss moduli followed those described above for 
storage moduli (Appendix C, CF2). All gels reached a maximum storage modulus at high 
angular frequency (Figure 9), and all gels were shear thinning (Appendix C, CF3), indicating 
potential injectability.20  
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Table 5. Average storage moduli of 1% (w/v) peptide hydrogels  
Peptide Unpolymerized (kPa) Polymerized (kPa) 
VEVA 85.5 ± 8.1 67.9 ± 2.1* 
VVEA 92.7 ± 20.4 35.8 ± 7.7 
IEIA 97.8 ± 14.5 44.0 ± 14.2 
IIEA 20.0 ± 5.7 28.0 ± 8.7 
VDVA 116.8 ± 16.0 100.1 ± 6.7 
VVDA 74.1 ± 4.3 117.0 ± 3.9 
IDIA 94.7 ± 7.8 80.6 ± 19.0 
IIDA 35.5 ± 9.0 27.8 ± 5.3 
* Two data points 
 
 
Figure 9. Storage modulus versus angular frequency for unpolymerized and polymerized gels. 
 
Rheological testing indicates that 1% by weight hydrogels made from this peptide library 
possess biologically relevant moduli after polymerization. The polymerized gels, ranging in 
moduli from 20-120 kPa, fall in the same range as breast (2-20 kPa), brain (30-100 kPa) and 
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heart tissues (10-5000 kPa).21 Though further testing is required to assess biocompatibility, these 
results are promising for the development of a conductive hydrogel for tissue engineering 
applications. 
 
Conclusions 
A library of 12 N-acylated thiophene-peptide hybrids was synthesized, eight of which 
successfully self-assembled into beta-sheet containing gels in the presence of exogenous EDOT-
OH. The resulting gels were polymerized with FeCl3, yielding gels with conductivity 
approaching that of pure CP and undoped silicon. Gels retained beta-sheet content and a fibrous 
structure after polymerization, leading to mechanical properties in the range of human soft 
tissues such as brain and heart. The two unpolymerized gels predicted to possess the highest 
mechanical properties based on known beta-sheet forming sequences exhibited the highest 
storage moduli before polymerization. A clear pattern was not observed in storage moduli 
following polymerization, as most polymerized gels exhibited a decrease in moduli compared to 
their unpolymerized counterparts. These observations require additional exploration before 
intentional peptide design becomes feasible. 
Future work for this project includes control testing to determine whether a CP moiety must be 
chemically attached to the peptide in order for the self-assembly process to template the CP. By 
replacing the thiophene group at the N-termini of the peptides with a benzene group that cannot 
participate in polymerization, a second library will be synthesized and interrogated for electrical, 
mechanical, and morphological features. Furthermore, while initial mechanical testing indicates 
that these hydrogels are shear-thinning, further mechanical testing is necessary to determine 
whether their viscosity is appropriate for injections delivered in a clinical setting. This testing 
involves both additional rheological experiments (e.g. strain sweep, cyclic strain sweep) and 
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injection force measurements when delivered through needles of various gauge. Finally, 
determining the biocompatibility of these materials is necessary before their introduction as an 
alternative to traditional metal electrodes.  
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Appendix A 
 
 
AF1. 1H NMR spectrum of thiophene-VEVA.  
 
 
31 
 
 
AF2. 1H NMR spectrum of thiophene-VVEA.  
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AF3. RP-HPLC trace of thiophene-VDVA showing 95% purity (top). 1H NMR spectrum of 
thiophene-VDVA (bottom).  
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AF4. RP-HPLC trace of thiophene-VVDA showing 93% purity (top). 1H NMR spectrum of 
thiophene-VVDA (bottom).  
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AF5. 1H NMR spectrum of thiophene-IEIA.  
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AF6. RP-HPLC trace of thiophene-IIEA showing 97% purity (top). 1H NMR spectrum of 
thiophene-IIEA (bottom).  
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AF7. RP-HPLC trace of thiophene-IDIA showing 89% purity (top). 1H NMR spectrum of 
thiophene-IDIA (bottom).  
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AF8. RP-HPLC trace of thiophene-IIDA showing 86% purity (top). 1H NMR spectrum of 
thiophene-IIDA (bottom). 
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AF9. 1H NMR spectrum of thiophene-FEFA.  
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AF10. 1H NMR spectrum of thiophene-FFEA.  
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AF11. 1H NMR spectrum of thiophene-LELA.  
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AF12. 1H NMR spectrum of thiophene-LLEA.  
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Appendix B 
 
FEFA and FFEA Gelation Attempts 
FEFA and FFEA (Fig. 1) were gelled at four different concentrations (0.75%, 1%, 1.5%, and 
3% (w/v)) following standard procedure and utilizing the components listed in Table BT1. No 
homogenous gels were observed, and peptide began to precipitate from the gels over the course 
of 30 min to several hours. The 3% gels remained intact for the longest amount of time, but still 
completely collapsed after seven hours undisturbed. It is hypothesized that initial assembly 
corresponds to the sorting of the hydrophobic and hydrophilic residues into beta-sheets, while the 
disruption in structure arises from pi-stacking between the aromatic phenyl rings. Heating the 
peptide solution during gelation did not prolong the stability of the gels and gels could not be 
reformed by sonicating and heating the collapsed solution.  
 
LELA and LLEA Gelation Attempts 
Likewise, thiophene-LELA gelation was attempted at 0.44% and 1.5 % (w/v) (BT1), but no 
gelation was observed in any case. Acidification resulted in immediate precipitation. Mixing 
thiophene-LELA at 0.7% (w/v) with 1:1 EDOT-OH and utilizing the buffered acid addition 
necessary to gel the phenylalanine peptide isomers did not result in the immediate formation of a 
gel (BT2). The aqueous solutions were left to rest overnight, which did not result in gelation. A 
subsequent addition of 100 µL p-TSA (0.2 M) resulted in precipitation. Thiophene-LELA and -
LLEA did not form stable gels under any conditions. 
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BT1. Phenylalanine and leucine gel study 
Peptide Peptide Mass 
(mg) 
[Gel] 
(w/v) 
np H2O 
(µL) 
1 M NaOH 
(µL) 
0.2 M p-TSA 
(µL) 
Homogenous 
Gel? 
FEFA 3.8 0.75% 365 15.0 120 No 
FFEA 3.8 0.75% 365 15.0 120 No 
FEFA 5.0 1.00% 80.0 5.0 415 No 
FFEA 5.0 1.00% 250 30.0 220 No 
FEFA 7.5 1.50% 250 30.0 220 No 
FFEA 7.5 1.50 % 250 30.0 220 No 
FEFA 15 3.00% 260 49.0 193† No 
FFEA 15 3.00% 260 49.0 193† No 
LELA 2.5 0.44% 80.0 5.0 415 No 
LLEA 5.0 1.00% 250 30.0 220 No 
† 0.5 M p-TSA 
 
A literature search concerning peptides with similar primary sequences to the peptide isomers 
in question indicated robust assembly achieved by lowering the solution pH very slowly, or 
hydrolyzing a lactone to evenly distribute protons throughout the aqueous peptide solution.22 To 
test that method, FEFA was dissolved in a sodium carbonate buffer solution, to which p-TSA 
(0.2 M) was added via a micropipette over several hours to induce gelation (BT2). Thiophene-
FEFA gelled strongly at 1.5% (w/v) using this method, prompting attempts to use the same 
method to form phenylalanine gels with 1:1 EDOT-OH. These experiments resulted in a 
transient gel that precipitated and collapsed before polymerization was complete. The FTIR 
spectra of the intact gel and the collapsed polymerized gel are nearly identical, both showing 
amide I peaks at 1633 cm-1 (BF1). This peak is indicative of beta-sheet content, but the collapsed 
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gel indicates that the hydrogen bonds between the beta-sheets were not enough to result in a 
robust, stable gel.  
 
Buffered Gelation Procedure: Lyophilized peptide-thiophene derivatives and sodium 
carbonate (1:2 mol ratio) were dissolved in npH2O while sonicating. Two molar equivalents of 
0.2 M p-TSA were added via a micropipette (5 µL/15 min) while sonicating and maintaining the 
bath temperature at 20 °C. Additional acid was added in one aliquot to induce gelation (BT2).  
 
BT2. Buffered gel components  
Peptide Peptide 
Mass (mg) 
EDOT-OH 
Mass (mg) 
NaHCO3 
Mass (mg) 
[Gel] 
(w/v) 
np H2O 
(µL) 
0.2 M p-
TSA (µL) 
Homogenous 
Gel? 
LELA 3.5 1.1 1.4 0.70% 440 60.0 No 
LLEA 5.0 1.5 1.9 1.00% 355 145 No 
FEFA 7.5 2.1 2.5 1.50% 265 235 Transient 
 
 
BF1.  FTIR spectra of wet thiophene-FEFA gels showing retention of beta-sheet assembly before 
and after polymerization and collapse. 
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Appendix C 
 
 
CF1. FTIR spectra of polymerized gels indicating retention of beta-sheet assembly.  
 
Equation 1. 𝜌 = 𝑠 ∗ 𝑑 
Where ρ is resistivity, s is the average measured sheet resistivity, and d is pellet thickness in cm. 
Equation 2. 𝜎 = 𝜌−1 
Where σ is conductivity and ρ is resistivity.  
 
The loss modulus of a gel relates to its ability to dissipate energy through stress relaxation.20 
PVDVA and PVVDA exhibited the highest loss moduli at approximately 15 kPa (CF2), followed 
by PIDIA and PIEIA at approximately 8 kPa. This pattern is also observed in the viscoelasticity 
of samples following polymerization (CF3), a parameter that gives insight into injectability of 
the tested hydrogels. All gels were shear-thinning, indicating potential injectability, but the 
magnitude of force required to extrude the gels from a syringe remains to be tested before 
assessing clinical relevance. A balance between storage modulus, loss modulus, and 
viscoelasticity must be achieved for successful injection.20 
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CF2. Loss moduli of gels pre- and post-polymerization indicating a similar trend in assembly 
strength as observed in storage moduli. 
 
 
CF3. Viscoelasticity of gels pre-and post-polymerization highlighting the shear-thinning 
properties of the library necessary for injectability.  
